Abstract:To understand the mechanisms of neuronal Zn2+ homeostasis better, experimental data obtained from cultured cortical neurons were used to inform a series of increasingly complex computational models. Total metals (inductively coupled plasma-mass spectrometry), resting metallothionein, 65Zn2+ uptake and release, and intracellular free Zn2+ levels using ZnAF-2F were determined before and after neurons were exposed to increased Zn2+, either with or without the addition of a Zn2+ ionophore (pyrithione) or metal che… Show more
“…CQ exerts its actions in other systems by acting as a moderate affinity Cu/Zn chelator and a Zn 2ϩ ionophore (7,8,20). Therefore, we investigated whether CQ activates TRPA1 by increasing the concentration of intracellular zinc ([Zn 2ϩ ] i ).…”
The antifungal and amoebicidal drug clioquinol (CQ) was withdrawn from the market when it was linked to an epidemic of subacute myelo-optico-neuropathy (SMON). Clioquinol exerts its anti-parasitic actions by acting as a Cu/Zn chelator and ionophore. Here we show that local injections of CQ produce mechanical hyperalgesia and cold hypersensitivity through a mechanism involving TRPA1 in mice. We also show that CQ activates TRPA1 in a Zn 2؉ pain ͉ sensory neurons ͉ TRP channels ͉ zinc T he antifungal and amoebicidal drug clioquinol (CQ) was once widely used to treat gastrointestinal disorders, but was withdrawn from oral preparations when CQ was linked to an epidemic of subacute myelo-optico-neuropathy (SMON) in Japanese patients. Patients with SMON suffer from sensory and motor disorders and visual impairment. Thirty years after the ban of oral CQ, 40% of patients with SMON are unable to walk independently and approximately 7% suffer from visual impairment. The most common complaints, however, have been different forms of sensory impairments, such as tactile hypo-and hypersensitivity (almost 90% of patients) and dysesthesias (97%) (1). Notably, almost 50% of patients experience pain and 40% have cold sensitivity. CQ also has acute sensory effects, and studies on isolated nociceptive fibers in dogs demonstrated that CQ recruited normally quiescent fibers to become sensitive to hyperosmotic stimuli and cold (2), suggesting a direct effect on sensory nerves.CQ exerts its anti-parasitic actions by acting as a moderate affinity Cu/Zn chelator and ionophore. The ionophore activity of CQ contributes to its neurotoxicity (3, 4), but also makes it a useful drug for the treatment of acrodermatitis enteropathica, a rare genetic disorder characterized by insufficient Zn 2ϩ uptake (5, 6). More recently CQ has been shown to reduce Cu/Zn deposits and beta-amyloid accumulation in transgenic mouse models of Alzheimer's disease (7,8), findings that have led to clinical trials of CQ in Alzheimer's patients (9, 10).TRPA1 is expressed in a subpopulation of dorsal root ganglion (DRG) neurons, where it acts as a sensory receptor for environmental irritants and both oxidation and thiol-reactive compounds, some of which are produced endogenously during oxidative stress (11-15). Furthermore, TRPA1 can be activated by increasing the osmolarity of the extracellular solution (16).Transgenic mice lacking TRPA1 have a reduced sensitivity to cold stimuli and punctate mechanical stimulation (17), in addition to a reduced chemical sensitivity to irritants and oxidants (11,12,17,18). The similarity between the modalities affected by CQ in nociceptive fibers (increased sensitivity to cold stimulation and hyperosmotic solutions) and the behavioral deficits of mice lacking TRPA1 (reduced sensitivity to painful cold and mechanical stimuli) led us to examine whether CQ can induce pain behavior acutely in mice through the activation of TRPA1.
ResultsPronociceptive Effects of Clioquinol. Tactile and cold hypersensitivity are very common symptoms in pati...
“…CQ exerts its actions in other systems by acting as a moderate affinity Cu/Zn chelator and a Zn 2ϩ ionophore (7,8,20). Therefore, we investigated whether CQ activates TRPA1 by increasing the concentration of intracellular zinc ([Zn 2ϩ ] i ).…”
The antifungal and amoebicidal drug clioquinol (CQ) was withdrawn from the market when it was linked to an epidemic of subacute myelo-optico-neuropathy (SMON). Clioquinol exerts its anti-parasitic actions by acting as a Cu/Zn chelator and ionophore. Here we show that local injections of CQ produce mechanical hyperalgesia and cold hypersensitivity through a mechanism involving TRPA1 in mice. We also show that CQ activates TRPA1 in a Zn 2؉ pain ͉ sensory neurons ͉ TRP channels ͉ zinc T he antifungal and amoebicidal drug clioquinol (CQ) was once widely used to treat gastrointestinal disorders, but was withdrawn from oral preparations when CQ was linked to an epidemic of subacute myelo-optico-neuropathy (SMON) in Japanese patients. Patients with SMON suffer from sensory and motor disorders and visual impairment. Thirty years after the ban of oral CQ, 40% of patients with SMON are unable to walk independently and approximately 7% suffer from visual impairment. The most common complaints, however, have been different forms of sensory impairments, such as tactile hypo-and hypersensitivity (almost 90% of patients) and dysesthesias (97%) (1). Notably, almost 50% of patients experience pain and 40% have cold sensitivity. CQ also has acute sensory effects, and studies on isolated nociceptive fibers in dogs demonstrated that CQ recruited normally quiescent fibers to become sensitive to hyperosmotic stimuli and cold (2), suggesting a direct effect on sensory nerves.CQ exerts its anti-parasitic actions by acting as a moderate affinity Cu/Zn chelator and ionophore. The ionophore activity of CQ contributes to its neurotoxicity (3, 4), but also makes it a useful drug for the treatment of acrodermatitis enteropathica, a rare genetic disorder characterized by insufficient Zn 2ϩ uptake (5, 6). More recently CQ has been shown to reduce Cu/Zn deposits and beta-amyloid accumulation in transgenic mouse models of Alzheimer's disease (7,8), findings that have led to clinical trials of CQ in Alzheimer's patients (9, 10).TRPA1 is expressed in a subpopulation of dorsal root ganglion (DRG) neurons, where it acts as a sensory receptor for environmental irritants and both oxidation and thiol-reactive compounds, some of which are produced endogenously during oxidative stress (11-15). Furthermore, TRPA1 can be activated by increasing the osmolarity of the extracellular solution (16).Transgenic mice lacking TRPA1 have a reduced sensitivity to cold stimuli and punctate mechanical stimulation (17), in addition to a reduced chemical sensitivity to irritants and oxidants (11,12,17,18). The similarity between the modalities affected by CQ in nociceptive fibers (increased sensitivity to cold stimulation and hyperosmotic solutions) and the behavioral deficits of mice lacking TRPA1 (reduced sensitivity to painful cold and mechanical stimuli) led us to examine whether CQ can induce pain behavior acutely in mice through the activation of TRPA1.
ResultsPronociceptive Effects of Clioquinol. Tactile and cold hypersensitivity are very common symptoms in pati...
“…5d). In addition, the Zn 2+ ionophore pyrithione (Colvin et al, 2008) caused the clearance of Zn 2+ from both young and old slices within 10 minutes (Fig. 5d), confirming that we observed uptake.…”
Section: Impaired Reuptake Of Extracellular Zinc By Older Hippocampalsupporting
“…2C). Extracellular application of TPEN, a small membranepermeable chemical that exhibits 10 11 times greater affinity for Zn 2+ than ZRL1 (Colvin et al, 2008), almost completely quenched ZRL1 fluorescence in non-α-cells within ∼100 s (quenching coefficient, 16±1% of the control, mean±s.e.m., n=9, Fig. 1D), but only marginally affected the fluorescence in EYFP-positive α-cells (quenching coefficient, 79±2% of the control, n=11, Fig.…”
Imbalanced glucagon and insulin release leads to the onset of type 2 diabetes. To pinpoint the underlying primary driving force, here we have developed a fast, non-biased optical method to measure ratios of pancreatic α-and β-cell mass and function simultaneously. We firstly label both primary α-and β-cells with the red fluorescent probe ZinRhodaLactam-1 (ZRL1), and then highlight α-cells by selectively quenching the ZRL1 signal from β-cells. Based on the signals before and after quenching, we calculate the ratio of the α-cell to β-cell mass within live islets, which we found matched the results from immunohistochemistry. From the same islets, glucagon and insulin release capability can be concomitantly measured. Thus, we were able to measure the ratio of α-cell to β-cell mass and their function in wild-type and diabetic Lepr db /Lepr db (denoted db/db) mice at different ages. We find that the initial glucose intolerance that appears in 10-week-old db/db mice is associated with further expansion of α-cell mass prior to deterioration in functional β-cell mass. Our method is extendable to studies of islet mass and function in other type 2 diabetes animal models, which shall benefit mechanistic studies of imbalanced hormone secretion during type 2 diabetes progression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.